Clinical trial
Ambulatory Tubeless Mini Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery in the Management of Nephrolithiasis: A Randomized Controlled Clinical Study
NCT04389853 is registered in ClinicalTrials.gov with Thunder Bay Regional Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ambulatory Tubeless Mini Percutaneous Nephrolithotomy Versus Retrograde Intrarenal Surgery in the Management of Nephrolithiasis: A Randomized Controlled Clinical Study
- Lead sponsor
- Thunder Bay Regional Health Research Institute
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 5, 2020
- Completion date
- April 24, 2024
- Enrollment
- 76 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
kidney stone, nephrolithiasis